Source: International Congress 2015 – IPF: an airway-derived disease?



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chilosi (Verona, Italy). Shared pathways of lung development and misled repair during pulmonary fibrosis. International Congress 2015 – IPF: an airway-derived disease?

Member's Comments

No comment yet.

Related content which might interest you: Shared epithelial pathways to lung repair and disease Source: Eur Respir Rev, 26 (144) 170048; 10.1183/16000617.0048-2017 Year: 2017 Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 αB-crystallin is involved in the process of pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 αB-crystallin is involved in the process of pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity Source: Annual Congress 2008 - Physiological year in review Year: 2008 Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis? Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Understanding the mechanisms and time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 559s Year: 2005 Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation Source: International Congress 2016 – Mechanisms of disease Year: 2016 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Targeting repair in lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same? Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 The cross-talk between TGF-ß and periostin can be targeted for pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010